Browse > Article

Effects of Mori Fructus Extract on Hyperglycemia, Hyperlipidemia, Polyol Pathway, AGE and RAGE in ob/ob Mice  

Lee, Min-Dong (Department of Internal Medicine, College of Korean Medicine, Dongguk University)
Jeong, Ji-Cheon (Department of Internal Medicine, College of Korean Medicine, Dongguk University)
Publication Information
Journal of Physiology & Pathology in Korean Medicine / v.23, no.2, 2009 , pp. 351-359 More about this Journal
Abstract
Etiological studies of diabetes and its complications showed that oxidative stress might play a major role, Therefore, many efforts have been tried to regulate free oxygen radicals for treating diabetes and its complications. Mori Fructus extract has been known to be effective for the antidiabetic, antihyperlipidemic and antiobesitic prescription, and composed of four crude herbs, The aim of this study was to investigate the effect of Mori Fructus extract in male ob/ob mouse with severe obesity, hyperinsulinemia, hyperglycemia, hyperlipidemia. Mice were grouped and treated for 5 weeks as follows. Both the lean (C57BL/6J black mice) and diabetic (ob/ob mice) control groups received standard chow. The experimental groups were fed with a diet of chow supplemented with 7.5, 15 and 30 mg Mori Fructus extract per 1 kg of body weight for 14 days. The effects of Mori Fructus extract on the ob/ob mice were observed by measuring the serum levels of glucose, insulin, lipid components, and the kidney levels of reactive oxygen species (ROS), MDA+HAE, GSH and also the enzyme activities involved in polyol pathway. Western blotting was performed using anti-AGE, anti-RAGE respectively. Mori Fructus extract lowered the levels of serum glucose and insulin in a dose dependent manner. Total cholesterol, triglyceride and free fatty acid levels were decreased, while the HDL-cholesterol level was increased, in Mori Fructus extract treated groups. Renal aldose reductase and sorbitol dehydrogenase activities were increased in the ob/ob mice, whereas those were inhibited in the Mori Fructus extract-administered groups. Mori Fructus extract inhibited the generation of ROS in the kidney. MDA+HAE level was increased and the GSH level was decreased in the ob/ob mice, whereas those were improved in the Mori Fructus extract-administered groups. Mori Fructus extract inhibited the expression of AGE, RAGE in the ob/ob mice. The results suggested that Mori Fructus exerted the antidiabetic and antihyperlipidemic activities by regulating the activities of polyol pathway enzymes, scavenging the ROS, decreasing the MDA+HAE level, increasing the GSH level and inhibiting the expression of AGE, RAGE in the ob/ob mice.
Keywords
Mori Fructus; ob/ob mouse; antidiabetic activities; polyol pathway; oxidative stress; AGE; RAGE;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 Pugliese, G., Tilton, G.T. and Williamson, J.R. Glucose- induced metabolic imbalance in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev. 7: 35-59, 1991   DOI   ScienceOn
2 한상태, 정지천. 淸血散이 ob/ob mouse의 혈당, 고지혈증, Polyol Pathway 및 Reactive Oxygen Species에 미치는 영향. 동의생리병리학회지 22(2):350-356, 2008
3 江蘇新醫學院 編. 中藥大辭典. 上海, 上海科學技術出版社, pp 1967-1968, 1983
4 라정찬, 배진희, 박형근, 김성훈, 강경선. 당뇨 환자를 위한 새로운 식이요법제에 관한 연구. 동의생리병리학회지 17(1):130-135, 2006
5 황금희. 상심자(Morus alba)의 운동능력 향상과 스트레스 개선 효과. 한국식품과학회지 37(1):95-102, 2005   과학기술학회마을
6 金井泉 외. 臨床檢査法槪要. 동경, 금원. p 467, 1983
7 정해주, 김세윤, 정지천. 고지방 식이 흰쥐의 비만에 미치는 三精丸의 영향. 대한한의학회지 27(3):516-527, 2006   과학기술학회마을
8 Eleazar, S. Animal models of non-insulin-dependent diabetes. Diabetes metabolism reviews. 8(3):179-208, 1992   DOI   PUBMED   ScienceOn
9 Carmine, M., Giuseppe, L., Bruno, T. Insulin resistance and cardiovascular risk ; New insight from molecular and cellular biology. Trends cardiovasc Med. 16: 183-188, 2006   DOI   ScienceOn
10 Hammers, H.D., Martin, S., Fedesrlin, K., Geisen, K. and Brownlee, M. Aminoguanidine treatment inhibit the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA. 88: 11555-11558, 1991   DOI   ScienceOn
11 余永譜. 中醫治療內分泌代謝疾病. 浙江, 浙江科學技術出版社, p 239, 243, 1992
12 Kahn, C.R. The molecular mechanism of insulin action. Ann Rev Med. 34: 145-160, 1985
13 Stevens, M.J., Dananberg, J., Feldman, E.L., Lattimer, S.A., Kamijo, M., Thomas, T.P., Shindo, H., Sima, A.A. and Greene, D.A. The linked roles of nitric oxide, aldose reductase and Na-K-ATPase in the slowing of nerve conduction in the streptozotocin diabetic rat. J Clin Invest. 94: 853-859, 1994   DOI   ScienceOn
14 Neeper, M., Schmidt, A.M., Brett, J., Yan, S.D., Wang, F., Pan, Y.C.E., Ellisoton, K., Stern, D. and shaw, A.J. Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. Biol Chem. 267: 14998-15004, 1992
15 강석봉. 消渴의 傳變證과 당뇨병의 만성합병증에 대한 비교 고찰. 대한한의학회지 19(2):137-152, 1998
16 Ellman, G.L. Tissue sulfhydryl group arch. Biochem Biophys. 82: 70-77, 1959   DOI   PUBMED   ScienceOn
17 全國韓醫科大學 本草學敎授 共編. 本草學. 서울, 永林社, pp 598-599, 1991
18 한기선. ob/ob mice에서 順氣散의 항당뇨 활성 및 기전 연구. 경희대학교 대학원 석사학위논문, 2002
19 Smith, P.R. and Thornalley, P.J. Mechanism of the degradation of non-enzymatically glycated proteins under physiological conditions. Eur J Biochem. 210: 729-739, 1992   DOI   ScienceOn
20 Schmidt, A.M., Vianna, M., Gerlach, M., Brett, J., Ryan, J., Kao, J., Seposito, C., Hegarty, H., Hurley, W. and Clauss, M. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung tissue which are present on the endothelial cell surface. J Biol Chem. 267: 14987-14997, 1992   PUBMED
21 方藥中. 實用中醫內科學. 上海, 上海科學技術出版社, p 477, 1986.
22 Thomson, R.H. Colorimetric glucose oxidase method for blood glucose. Clin Chem Acta. 13: 133-135, 1966   DOI   ScienceOn
23 Flether, M.J. A colorimetric method for estimation serum triglyceride. Clin Chem. 22: 393, 1968   DOI   ScienceOn
24 Yamaoka, T., Nishimura, C., Yamashita, K., Itakura, M., Yamada, T., Fujimoto, J. and 3Kokai, Y. Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA. Diabetologia. 38: 255-261, 1995   DOI   ScienceOn
25 박용기, 강병수. 桑椹子의 항산화작용에 관한 연구. 대한본초학회지 14(2):43-50, 1999
26 Polonsky, K.S. et al. Non-insulin dependent diabetes mellitus. A genetically programmed failure of the $\beta$ cell to compensate for insulin resistance. New Engl J Med. 334: 777-783, 1998   DOI   ScienceOn
27 Cai, H., Harrison, D.G. Endothelial dysfunction in cardiovascular diseases ; the role of oxidant stress. Circ Res. 87: 840-844, 2000   DOI   PUBMED
28 Hollmann, S. In Hoppe-Seyler Thiefelder : Handbuch der physiol. und path.-chem. Vol. VIa. Berlin-Heidelberg-New York:Analyse, Springer. p 704, 1964
29 Vinson, J.A. and Howard, T.B. Inhibition of protein glycation and advanced glycation end products by ascorbic and other vitamines and nutrients. Nutritional Biochemistry. 7: 659-663, 1996   DOI   ScienceOn
30 Matsubara, T., Ziff, M. Increased syperoxide anion release from human endothelial cells in response to cytokines. J Immunol. 137: 3295-3298, 1986.
31 Schmidt, A.M., Yan, S.D., Wautier, J.L. and Stern, D. Activation of receptor for advanced glycosylation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res. 84: 489-497, 1999   DOI   PUBMED
32 Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J. Protein measurement with folin phenol reagent. J Biol Chem. 193: 265-275, 1951   PUBMED
33 Schleicher, E.D., Wagner, E., Nerlich, A.G. Increasedaccumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging. J Clin Invest. 99(3):457-468, 1997   DOI   ScienceOn
34 김응진 외. 당뇨병학. 서울, 고려의학, pp 15-43, 32-33, 149-169, 391-468, 475-487, 609-616, 1998
35 Steinberg, G.R. Inflammation in obesity is the common link between defects in fatty acid metabolism and insulin resistance. Cell Cycle. 6: 888-894, 2007   DOI   PUBMED   ScienceOn
36 Levinson, S.S. Use of an enzymatic method for cholesterol, designed for continuous flow instrumention, with discrete bichromatic and centrifugation analysis. Clin Chem. 23: 2335-2337, 1977   PUBMED
37 Clay, F.S. Insulin resistance and atherosclerosis. J Clin Invest. 116: 1813-1822, 2006   DOI   ScienceOn
38 Brownlee, M., Cerami, A. and Vlassara, H.N. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. Engl J Med. 318: 1315-1321, 1988   DOI   ScienceOn
39 Cathcart, R., Schwiers, E., Ames, B.N. Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein fluorescent assay. Anal Biochem. 134: 111-116, 1983   DOI   ScienceOn
40 Esterbauer, H., Schaur, R.J. and Zollner, H. Chemistry and Biochemistry of 4-Hydroxynonenal, Malondialdehyde and Related Aldehydes. Free Rad Biol Med. 11: 81-128, 1991   DOI   ScienceOn